Your browser doesn't support javascript.
loading
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling.
Laplantine, Emmanuel; Chable-Bessia, Christine; Oudin, Anne; Swain, Jitendryia; Soria, Adèle; Merida, Peggy; Gourdelier, Manon; Mestiri, Sarra; Besseghe, Indira; Bremaud, Erwan; Neyret, Aymeric; Lyonnais, Sebastien; Favard, Cyril; Benaroch, Philippe; Hubert, Mathieu; Schwartz, Olivier; Guerin, Maryse; Danckaert, Anne; Del Nery, Elaine; Muriaux, Delphine; Weil, Robert.
Afiliação
  • Laplantine E; Sorbonne Universités, Institut National de la Santé et de la Recherche Médicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.
  • Chable-Bessia C; CEMIPAI, Montpellier University, UAR3725 CNRS, Montpellier, France.
  • Oudin A; Sorbonne Universités, Institut National de la Santé et de la Recherche Médicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.
  • Swain J; Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, UMR9004 CNRS, Montpellier, France.
  • Soria A; Institut Curie, PSL Research University, Department of Translational Research-Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), 75005 Paris, France.
  • Merida P; Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, UMR9004 CNRS, Montpellier, France.
  • Gourdelier M; Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, UMR9004 CNRS, Montpellier, France.
  • Mestiri S; Sorbonne Universités, Institut National de la Santé et de la Recherche Médicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.
  • Besseghe I; Sorbonne Universités, Institut National de la Santé et de la Recherche Médicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.
  • Bremaud E; Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, UMR9004 CNRS, Montpellier, France.
  • Neyret A; CEMIPAI, Montpellier University, UAR3725 CNRS, Montpellier, France.
  • Lyonnais S; CEMIPAI, Montpellier University, UAR3725 CNRS, Montpellier, France.
  • Favard C; Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, UMR9004 CNRS, Montpellier, France.
  • Benaroch P; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, 75005 Paris, France.
  • Hubert M; Institut Pasteur, Virus and Immunity Unit, Department of Virology, Paris, France.
  • Schwartz O; Centre National de la Recherche Scientifique (CNRS, UMR3569), Paris, France.
  • Guerin M; Institut Pasteur, Virus and Immunity Unit, Department of Virology, Paris, France.
  • Danckaert A; Centre National de la Recherche Scientifique (CNRS, UMR3569), Paris, France.
  • Del Nery E; National Institute for Health and Medical Research (INSERM) UMRS 1166, Faculty of Medicine Pitié-Salpêtrière, 91 Bld de L'Hôpital, 75013 Paris, France.
  • Muriaux D; Institut Pasteur, UTechS Photonic BioImaging (PBI) - C2RT, Paris, France.
  • Weil R; Institut Curie, PSL Research University, Department of Translational Research-Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), 75005 Paris, France.
iScience ; 25(10): 105066, 2022 Oct 21.
Article em En | MEDLINE | ID: mdl-36093378

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França